Weekly Spotlight - 14.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Men's Health Awareness: NRAS Live Event on Rheumatoid Arthritis

Join NRAS Live on 27th November at 7pm for Men's Health Awareness Month. The event highlights men's health, focusing on rheumatoid arthritis (RA). Stuart Munday and Krystian Lamb, who shares his RA journey, will speak. Watch online or on social media, and submit questions in advance for discussion.

Biologics Reduce Cardiovascular Risk in Rheumatoid Arthritis Patients

Biologic therapies for rheumatoid arthritis (RA) improve disease activity and enhance PON1 activity, reducing cardiovascular risk. A study found significant PON1 increases, especially with tocilizumab, linked to better treatment responses. This suggests RA management with biologics may lower cardiovascular risks, offering hope for patients.

Gut Microbiome Changes Predict Rheumatoid Arthritis Onset

Researchers found that changes in the gut microbiome, particularly an increase in Prevotella strains, signal the onset of rheumatoid arthritis (RA) about 10 months prior. This discovery offers hope for early detection and intervention, potentially improving outcomes for those at risk of developing RA.

Rurality's Limited Impact on Veteran Rheumatoid Arthritis Care Disparities

The study found only modest differences in biologic therapy initiation for rheumatoid arthritis among veterans in rural and urban areas. This suggests that rurality isn't a major factor in care disparities. Other factors may explain these differences, highlighting the need for further investigation into veteran healthcare disparities.